Filamon is committed to the integration of Environmental, Social and Governance (ESG) considerations across all facets of its scientific and clinical programs and in its corporate processes and decision-making.

Filamon’s intention to commit to continuous improvement of its ESG performance demonstrates an experienced, well-informed Board and management attitude and a values-led culture that is vigilant and responsive to the challenges and opportunities of conducting a drug development business responsibly and sustainably.

• Manage all resources, including funds and human capital, with an ethos of sustainability and sound risk mitigation
• Conduct sound vendor verification at all levels of the Company, particularly supply chains
• Position Filamon as an employer of choice to attract and retain top talent
• Continuously work towards identifying technologies, materials, facilities and funds in responsible and innovative ways
• Adherence to all requirements of financial and regulatory Corporate Governance
• Demonstrate a company culture of diversity and inclusiveness of all kinds